VanEck Biotech ETF
BBH
BBH
81 hedge funds and large institutions have $333M invested in VanEck Biotech ETF in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
18% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 28
56% less call options, than puts
Call options by funds: $3.69M | Put options by funds: $8.31M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
81
Holding in Top 10
–
Calls
$3.69M
Puts
$8.31M
Top Buyers
| 1 | +$17.5M | |
| 2 | +$2.11M | |
| 3 | +$2.08M | |
| 4 |
Citigroup
New York
|
+$1.69M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$915K |
Top Sellers
| 1 | -$53.3M | |
| 2 | -$15.8M | |
| 3 | -$4.84M | |
| 4 |
Jane Street
New York
|
-$3.63M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.49M |